Trials / Conditions / IgG4-RD
IgG4-RD
3 registered clinical trials studyying IgG4-RD — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases NCT06978738 | Changzhou No.2 People's Hospital | Phase 1 |
| Terminated | Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD) NCT04918147 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Study to Evaluate the Effect of XmAb®5871 on Disease Activity in Patients With IgG4-Related Disease (RD) NCT02725476 | Xencor, Inc. | Phase 2 |